Dr. Ilya Kleyn

Qualifications and Experience

Education
Medical School — Azerbaijan Medical University
Saint Vincent Catholic Medical Center, Residency in Internal Medicine
Saint Vincent Catholic Medical Center, Fellowship in Geriatrics

Specialties
Primary Care Doctor (Internist)
Geriatrics

Professional Statement
Dr. Ilya Kleyn is a Board-Certified Internist serving the downtown
Manhattan area and its patients. He finished his Residency in Internal
Medicine at St. Vincent’s Catholic Medical Center and went on to
receive a Fellowship in Geriatrics, also from St. Vincent’s. He is an
attending Physician at Beth Israel Medical Center and also has his
extremely convenient private practice, located at 225 Broadway.

Dr. ILYA KLEYN is Board Certified in both Internal Medicine and
Geriatric Medicine. He has been practicing medicine for more than 18
years.  He chose Internal Medicine for his residency and finished
with a Geriatric fellowship at New York Medical College at St.
Vincent’s Catholic Medical Center. His method of practice incorporates
a fusion of traditional and alternative medicine. His expertise is in
the treatment of high cholesterol, diabetes, obesity, and other
ailments using traditional and alternative approaches by emphasizing
balanced diets and liver cleansing techniques.

Research Experience 
Principal Investigator:
Clinical Trial Name and Protocol Number (the “Clinical Trial”):
VX14-787-103:       A Phase 2b,
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group,
Multicenter Study of 2 Dose Levels of VX-787 Administered as
Monotherapy and One Dose Level of VX-787 Administered in Combination
With Oseltamivir for the Treatment of Acute Uncomplicated Seasonal
Influenza A in Adult Subjects, 2014

Principal Investigator:
Sponsor: Boeringer-Ingelheim . A randomised, double-blind,
placebo-controlled, parallel group, efficacy and safety study of
empagliflozin (10 mg, 25 mg) administered orally, once daily over 24
weeks in hypertensive black/African American patients with type 2
diabetes mellitus, 2014.

Principal Investigator:
PrecisionMed Protocol 8009 SAMPLE Registry
Serial Alzheimer’s disease and MCI Prospective Longitudinal Evaluation, 2013

Principal Investigator:
ANALGESIC ACTIVITY OF TOPICAL PAIN CREAM IN PATIENTS WITH CHRONIC PAIN 2014

Principal Investigator:
SPONSOR: SeraTrials, A Bioreclamation Company
PROTOCOL NO: 05035 PROTOCOL TITLE: Prospective Collection of Samples for Research
Studies with this sponsor for following indications:
Asthma, COPD, Hepatitis C, HIV, Diabetes

Principal Investigator:
SPONSOR: SeraTrials, A Bioreclamation Company
A study to collect nasal or throat swabs for patients exhibiting flu-like symptoms, 2014.